0.205
13.38%
+0.0234
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TNXP Giù?
Forum
Previsione
Frazionamento azionario
Tonix Pharmaceuticals Holding Corp Borsa (TNXP) Ultime notizie
Why Tonix Pharmaceuticals (TNXP) Shares Are Plummeting - MSN
MSN
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - Yahoo Finance
Yahoo Finance
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights - GlobeNewswire
GlobeNewswire
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights - 13.05.2024 - wallstreet:online
wallstreet:online
Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com - Defense World
Defense World
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) to Post Q2 2024 Earnings of ($0.29) Per Share, Zacks Small ... - Defense World
Defense World
TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025… - Yahoo Finance
Yahoo Finance
StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - Defense World
Defense World
Noble Capital slashes Tonix Pharma share target on future sales outlook - Investing.com Canada
Investing.com Canada
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
GlobeNewswire Inc.
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On? - Tonix Pharmaceuticals (NAS - Benzinga
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
GlobeNewswire Inc.
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated - Tonix Pharmaceuticals (NASDAQ:TNXP) - Benzinga
Benzinga
Tonix's TNX-2900 gains FDA rare pediatric disease tag - Investing.com
Investing.com
3 Mind-Blowing Stocks That Could Turn $1000 Into $1 Million - InvestorPlace
InvestorPlace
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin ... - Yahoo Finance
Yahoo Finance
Tonix Pharma Readies for Tonmya™ U.S. Launch and Production - TipRanks.com - TipRanks
TipRanks
Tonmya advances towards FDA submission for fibromyalgia By Investing.com - Investing.com
Investing.com
Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024
GlobeNewswire Inc.
Tonix to market migraine treatments as it gears for new drug launch - Investing.com
Investing.com
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
GlobeNewswire Inc.
TNXP: Tonmya™ May Launch Alongside Another New Fibromyalgia Treatment… - Yahoo Finance
Yahoo Finance
Tonmya shows promise in Phase 3 fibromyalgia study By Investing.com - Investing.com
Investing.com
Sublingual Bedtime Treatment Aids Sleep and Reduces PTSD in Veterans - Sleep Review
Sleep Review
Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy
GlobeNewswire Inc.
Tonix's PTSD treatment shows promise in early study - Investing.com
Investing.com
Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya ... - GlobeNewswire
GlobeNewswire
Tonix Pharma Advances with Promising TNX-1500 Studies - TipRanks.com - TipRanks
TipRanks
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified ... - Yahoo Finance
Yahoo Finance
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L ... - Yahoo Finance
Yahoo Finance
Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to ... - Yahoo Finance
Yahoo Finance
Drug Candidate Helps Fibromyalgia Pain by Boosting Sleep Quality - Sleep Review
Sleep Review
3 Top Penny Stocks for 5000% Upside in 2024 and Beyond - Markets Insider
Markets Insider
Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference
GlobeNewswire Inc.
Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference - Yahoo Finance
Yahoo Finance
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032 - GlobeNewswire
GlobeNewswire
Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024
GlobeNewswire Inc.
Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA ... - GlobeNewswire
GlobeNewswire
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the ... - Yahoo Finance
Yahoo Finance
Tonix's PTSD drug cleared for phase 2 trauma trial - Investing.com
Investing.com
Tonix Pharma Discloses COPCs Linked to Long COVID Risk - TipRanks.com - TipRanks
TipRanks
Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID
GlobeNewswire Inc.
Tonix Pharma Announces FDA's Conditional Acceptance of Tonmya™ - TipRanks.com - TipRanks
TipRanks
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia
GlobeNewswire Inc.
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the ... - GlobeNewswire
GlobeNewswire
Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P.
GlobeNewswire Inc.
Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P. - GlobeNewswire
GlobeNewswire
TNXP: Positive Results for Phase 3 RESILIENT Trial Sets Up NDA Filing in 2H24… - Yahoo Finance
Yahoo Finance
Tonix Pharmaceuticals scores in second Phase III TNX-102 fibromyalgia trial - Clinical Trials Arena
Clinical Trials Arena
Capitalizzazione:
|
Volume (24 ore):